MLXIPL and metabolic dysfunction-associated steatotic liver disease: Increased hepatic ChREBP expression is also associated with NAFLD and insulin resistance in obese humans [70], but a direct effect of ingested fructose on ChREBP in human liver has not yet been demonstrated.